Kavar Capital Partners Group’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $14.1M | Sell |
28,722
-320
| -1% | -$174K | 1.77% | 13 |
|
|
2025
Q4 | $16.8M | Sell |
29,042
-471
| -2% | -$266K | 2.32% | 9 |
|
|
2025
Q3 | $14.3M | Buy |
29,513
+46
| +0.2% | +$21.4K | 1.91% | 11 |
|
|
2025
Q2 | $11.9M | Buy |
29,467
+162
| +0.6% | +$67.7K | 1.72% | 12 |
|
|
2025
Q1 | $14.6M | Buy |
29,305
+425
| +1% | +$230K | 2.43% | 9 |
|
|
2024
Q4 | $15M | Sell |
28,880
-35
| -0.1% | -$19.2K | 2.54% | 9 |
|
|
2024
Q3 | $17.9M | Sell |
28,915
-464
| -2% | -$275K | 2.83% | 6 |
|
|
2024
Q2 | $16.2M | Sell |
29,379
-378
| -1% | -$217K | 2.93% | 8 |
|
|
2024
Q1 | $17.3M | Sell |
29,757
-30,151
| -50% | -$16.9M | 3.19% | 6 |
|
|
2023
Q4 | $31.8M | Buy |
59,908
+30,319
| +102% | +$14.7M | 3.55% | 5 |
|
|
2023
Q3 | $15M | Buy |
29,589
+220
| +0.7% | +$117K | 3.25% | 5 |
|
|
2023
Q2 | $15.3M | Buy |
29,369
+562
| +2% | +$303K | 3.27% | 5 |
|
|
2023
Q1 | $16.6M | Sell |
28,807
-15
| -0.1% | -$8.45K | 3.58% | 5 |
|
|
2022
Q4 | $15.9M | Buy |
28,822
+599
| +2% | +$317K | 3.66% | 5 |
|
|
2022
Q3 | $14.3M | Buy |
28,223
+383
| +1% | +$214K | 3.65% | 4 |
|
|
2022
Q2 | $15.1M | Buy |
27,840
+262
| +1% | +$144K | 3.51% | 4 |
|
|
2022
Q1 | $16.3M | Buy |
27,578
+981
| +4% | +$564K | 3.52% | 3 |
|
|
2021
Q4 | $17.7M | Sell |
26,597
-51
| -0.2% | -$31.8K | 3.69% | 3 |
|
|
2021
Q3 | $15.2M | Buy |
26,648
+270
| +1% | +$148K | 3.47% | 4 |
|
|
2021
Q2 | $13.3M | Buy |
26,378
+921
| +4% | +$435K | 3.21% | 5 |
|
|
2021
Q1 | $11.6M | Buy |
25,457
+1,614
| +7% | +$770K | 3.13% | 6 |
|
|
2020
Q4 | $11.1M | Buy |
23,843
+1,810
| +8% | +$849K | 3.19% | 4 |
|
|
2020
Q3 | $9.73M | Sell |
22,033
-136
| -0.6% | -$56.2K | 3.28% | 4 |
|
|
2020
Q2 | $8.03M | Sell |
22,169
-318
| -1% | -$107K | 3.08% | 5 |
|
|
2020
Q1 | $6.38M | Sell |
22,487
-1,675
| -7% | -$528K | 3.06% | 4 |
|
|
2019
Q4 | $7.85M | Buy |
24,162
+425
| +2% | +$129K | 2.91% | 5 |
|
|
2019
Q3 | $6.91M | Buy |
23,737
+645
| +3% | +$185K | 2.7% | 6 |
|
|
2019
Q2 | $6.78M | Sell |
23,092
-454
| -2% | -$125K | 2.67% | 4 |
|
|
2019
Q1 | $6.45M | Buy |
23,546
+87
| +0.4% | +$21.7K | 2.87% | 3 |
|
|
2018
Q4 | $5.25M | Buy |
23,459
+1,085
| +5% | +$255K | 2.83% | 7 |
|
|
2018
Q3 | $5.46M | Buy |
22,374
+50
| +0.2% | +$11.5K | 2.71% | 6 |
|
|
2018
Q2 | $4.62M | Sell |
22,324
-15
| -0.1% | -$3.18K | 2.32% | 7 |
|
|
2018
Q1 | $4.61M | Sell |
22,339
-50
| -0.2% | -$10.5K | 2.41% | 5 |
|
|
2017
Q4 | $4.25M | Buy |
22,389
+225
| +1% | +$43.1K | 2.26% | 9 |
|
|
2017
Q3 | $4.19M | Buy |
22,164
+850
| +4% | +$154K | 2.3% | 8 |
|
|
2017
Q2 | $3.72M | Buy |
21,314
+125
| +0.6% | +$21K | 2.02% | 10 |
|
|
2017
Q1 | $3.25M | Buy |
21,189
+2,198
| +12% | +$336K | 1.81% | 14 |
|
|
2016
Q4 | $2.68M | Buy |
18,991
+3,545
| +23% | +$523K | 1.7% | 17 |
|
|
2016
Q3 | $2.46M | Buy |
15,446
+560
| +4% | +$86.3K | 1.58% | 19 |
|
|
2016
Q2 | $2.2M | Buy |
14,886
+540
| +4% | +$79.7K | 1.42% | 24 |
|
|
2016
Q1 | $2.03M | Buy |
14,346
+14,170
| +8,051% | +$1.9M | 1.34% | 26 |
|
|
2015
Q4 | $24K | Hold |
176
| – | – | 0.02% | 215 |
|
|
2015
Q3 | $21K | Hold |
176
| – | – | 0.01% | 226 |
|
|
2015
Q2 | $22K | Buy |
+176
| New | +$22.9K | 0.02% | 239 |
|
|
2014
Q2 | – | Sell |
-401
| Closed | -$48K | – | 410 |
|
|
2014
Q1 | $48K | Hold |
401
| – | – | 0.04% | 201 |
|
|
2013
Q4 | $44K | Buy |
+401
| New | +$39.9K | 0.04% | 201 |
|
Other funds holding TMO
VCM
